Serum vascular endothelial growth factor changes and safety after topical anti-human VEGF antibody bevacizumab in healthy dogs.

Publikationen als Autor:in / Herausgeber:in der Vetmeduni

Nell, Barbara; Tichy, Alexander

Schlagwörter

Administration, Ophthalmic; Animals; Bevacizumabadministration & dosageadverse effectspharmacology; Dogs; Eyedrug effects; Humans; Male; Ophthalmic Solutions; Single-Blind Method; Vascular Endothelial Growth Factor Aantagonists & inhibitorsblood

CC Lizenz

CCBY

ISSN/eISSN

1463-5216 -

WoS ID

WOS:000485981800006